Announcements Trials
Browse Landscape

Phase

Phase 2 37Phase 3 14Phase 1 8Phase NA 4Phase 1/2 3Phase 2/3 2Phase 4 1

Status

Recruiting 16Unknown 14Completed 10Terminated 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Lymphoma, Follicular 1Cholangiocarcinoma 1

Interventions

Carboplatin 9Paclitaxel 8Gemcitabine 8Cisplatin 8Cyclophosphamide 7Fluorouracil 6Docetaxel 5Capecitabine 5Granulocyte Colony-Stimulating Factor 4Etoposide 4Vinorelbine 3Stem Cell Transplantation 3Radiotherapy 3Pemetrexed 3Melphalan 3Leucovorin 3Filgrastim 3Erlotinib Hydrochloride 3Bone Marrow Transplantation 3Bevacizumab 3umbralisib 2ublituximab 2pembrolizumab 2peginterferon alfa-2b 2fludarabine 2Whole-Body Irradiation 2Trastuzumab 2Transplantation, Homologous 2Surveys and Questionnaires 2Surgical Procedures, Operative 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2/3 × Terminated × Drug Therapy × Clear all
NCT02807181 2025-05-09

SIRCCA

Sirtex Medical

Phase 2/3 Terminated
89 enrolled 23 charts
Gastrointestinal

Cholangiocarcinoma

NCT00096460 2023-01-05

BMT CTN 0202

Medical College of Wisconsin

Phase 2/3 Terminated
30 enrolled 5 charts
Lymphoid

Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡